Acceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatment

Simple item page
dc.article.end-page136en
dc.article.start-page129en
dc.citation.doi10.5588/IJTLDOPEN.24.0569en
dc.contributor.authorSE Purchaseen
dc.contributor.authorJ Brigdenen
dc.contributor.authorJA Seddonen
dc.contributor.authorNA Martinsonen
dc.contributor.authorLee Fairlieen
dc.contributor.authorE et alen
dc.date.accessioned2026-04-20T19:11:30Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationDOAJen
dc.identifier.urihttps://hdl.handle.net/10539/49084
dc.journal.titleAcceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatmenten
dc.journal.volume2en
dc.titleAcceptability of a 250 mg levofloxacin formulation in children receiving TB preventive treatmenten
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.61 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)